Isolation and identification of SARS-CoV-2 antibodies from COVID-19 patient samples
<p>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is the causing agent for COVID-19, has led to over 7 million deaths since it was first detected in Wuhan, China in December 2019. Antibodies induced by both vaccination and infection are crucial for the immune protection ag...
Κύριος συγγραφέας: | Liu, C |
---|---|
Άλλοι συγγραφείς: | Screaton, GR |
Μορφή: | Thesis |
Γλώσσα: | English |
Έκδοση: |
2024
|
Θέματα: |
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
SARS-CoV-2 infection induces robust mucosal antibody responses in the upper respiratory tract
ανά: Alba Escalera, κ.ά.
Έκδοση: (2024-03-01) -
Variant-specific antibody response following repeated SARS-CoV-2 vaccination and infection
ανά: Xiao-Lin Jiang, κ.ά.
Έκδοση: (2024-07-01) -
Broad sarbecovirus neutralization by combined memory B cell antibodies to ancestral SARS-CoV-2
ανά: Cyril Planchais, κ.ά.
Έκδοση: (2024-07-01) -
SARS-CoV-2 neutralizing antibodies in patients with varying severity of acute COVID-19 illness
ανά: Jeewandara, C, κ.ά.
Έκδοση: (2021) -
Cross-reactive immunity to SARS-CoV-2 and related coronaviruses
ανά: Jay, C
Έκδοση: (2023)